Please block out these dates in your schedule now, so you will be able to join us. The meeting will be in London, probably at our usual venue, BMA House.

We will be running our Call for Papers during July and August, but we also welcome suggestions for speakers or topics at any time – please feel free to send an email or give me a call to discuss your ideas.

Registration for the 2025 Conference will open in October, with early-bird discounts available in October and November. You could make a ‘to do’ note now, so you remember to take advantage of this!

Sponsors will, once again, be able to give lightning talks at the Conference; early sponsorship ensures maximum publicity, so please encourage your marketing department to enquire about our sponsorship opportunities right away.

Please look at the informative guidance about the Call for Papers on the R2R Website, and make your proposal soon!

25 February, 2025
Course
Virtual school of nebulisation of drugs for treatment of respiratory infections and disease – in collaboration with the Horizon 2020 FAIR project

Complimentary Webinar

Tuesday, February 25 at 1 pm ET
REGISTER NOW
Healthcare consumers now expect personalized, seamless experiences that anticipate their needs. But how can healthcare organizations actually achieve this?

Join this webinar for an engaging conversation about how to reimagine the customer journey. Learn how to harness the power of data to exceed customer expectations and drive meaningful outcomes.

SPEAKER
Tom Swanson
Head of Healthcare Strategy and Marketing
Adobe

MODERATOR
Maria Casteullucci
Deputy Editor, Custom Content
Modern Healthcare

What you'll learn:
Actionable steps to integrate data without adding complexity for clinicians.
The types of data that drive meaningful engagement and better outcomes.
Real-world examples of how health systems and payers are using customer data effectively.
REGISTER NOW: https://event.webcasts.com/starthere.jsp?ei=1706250&tp_key=37f48c107a&sti=html1&utm_source=Sailthru&utm_medium=email&utm_campaign=CustomWebinar-Adobe-%231-20250205&utm_term=Webinars-Adobe-Barrese-20250109

Please block out these dates in your schedule now, so you will be able to join us. The meeting will be in London, probably at our usual venue, BMA House.

We will be running our Call for Papers during July and August, but we also welcome suggestions for speakers or topics at any time – please feel free to send an email or give me a call to discuss your ideas.

Registration for the 2025 Conference will open in October, with early-bird discounts available in October and November. You could make a ‘to do’ note now, so you remember to take advantage of this!

Sponsors will, once again, be able to give lightning talks at the Conference; early sponsorship ensures maximum publicity, so please encourage your marketing department to enquire about our sponsorship opportunities right away.

Please look at the informative guidance about the Call for Papers on the R2R Website, and make your proposal soon!

https://events.bizzabo.com/665506?utm_source=Wiley&utm_medium=Newsletter

Cell Therapy: CAR T-Cells 

Join us at the BioProcess Forum to uncover the latest advancements in cell therapy and dive into pioneering CAR T-cell manufacturing at our immersive full-day event.

The BioProcess Forum is a virtual event series that offers a comprehensive exploration of bioprocessing. Designed for industry professionals, it covers a broad spectrum of topics from gene therapy fundamentals to advanced continuous and automated bioprocessing. This forum serves as a unique platform for both seasoned professionals and newcomers to connect, engage in insightful discussions, and stay updated with the latest trends and advancements in the field. It's an opportunity to be part of the conversation shaping the future of bioprocessing.

Is there a particular topic you wish to be covered in an upcoming event? Are you interested in speaking at an upcoming event? Please reach out to our Editor, Dr. Christene A. Smith, by email [email protected].

https://events.bizzabo.com/665506?utm_source=Wiley&utm_medium=Newsletter

Renal Genetics in 2025 and Beyond: What's Ahead for This Emerging and Dynamic Field?

KDIGO CME Webinar

Wednesday, February 26, 2 PM EST

Mark your calendar for Renal Genetics in 2025 and Beyond: What's Ahead for this Emerging and Dynamic Field, module four of the KDIGO Webinar Series on Implementing Genetic Testing for CKD in the Real World Setting.

Join professors Andrew Mallett, MD (Australia), Nine V.A.M. Knoers, MD (The Netherlands), Matthew Sampson, MD (United States), and Ulla Schultheiss, MD (Germany) as they delve into the evolving landscape of genetic testing in nephrology. From advancements in testing methodologies to polygenic risk scores and precision therapies for genetic kidney diseases, this webinar will offer a comprehensive exploration of the rapidly evolving field.

Participants will earn 1.0 CME credit and gain insights into optimizing test evaluation, understanding clinical applications, and addressing the limitations of genetic testing. Visit the series website for CME info, to learn more, and register.

Published every 4 years to coincide with federal leadership transitions, the National Academy of Medicine’s Vital Directions for Health and Health Care series analyzes the top health policy needs for the nation. The 2025 edition, published January 22 in Health Affairs, presents an expert overview of six key priorities: transforming health care payment and delivery; integrating AI into health care; modernizing public health; addressing the health impacts of climate change; improving women’s health; and advancing the biomedical research enterprise. As leaders inside and outside government navigate complex challenges, the Vital Directions series provides actionable, evidence-based guidance.
Register for the Virtual Briefing on February 27, 2025

https://nam.edu/initiatives/vital-directions-for-health-and-health-care/

Scaling Security in Healthcare: Strategies for Securing Healthcare in a Dynamic Digital Era

Thursday, February 27 | 11:00 AM CT

Join the webinar

The healthcare landscape is shifting toward a more distributed care model, improving patient access to care while increasing operational complexity for healthcare delivery organizations. This session will examine strategies for Health IT and Cybersecurity teams to optimize operations, reduce inefficiencies, and establish a secure, resilient digital environment. By enabling seamless access to essential systems and data for both clinical and non-clinical staff, organizations can ensure the delivery of patient-centered care anytime, anywhere.

During this session, subject-matter experts will discuss:

Examine the challenges and opportunities arising from the transition to a distributed care model within healthcare organizations
Explore strategies for Health IT and Cybersecurity teams to optimize operational efficiency, minimize inefficiencies, and navigate the complexities of modern healthcare delivery systems
Identify technologies and tools that enhance workflows while ensuring a secure, seamless, and consistent digital experience for clinicians, staff, and patients

Yes, I'd like to attend: https://event.on24.com/wcc/r/4842300/145F587665C4F715E6FE0C18246965A7?partnerref=email?leadId=2693643

Vital Directions for Health & Health Care: Priorities for 2025
Virtual Briefing | February 27 | 12:00 to 1:00 pm ET
Register Now

Published every 4 years to coincide with federal leadership transitions, the National Academy of Medicine’s Vital Directions for Health and Health Care series analyzes the top health policy needs for the nation. The 2025 edition, published January 22 in Health Affairs, lays out six key priorities: transforming health care payment and delivery; integrating AI into health care; modernizing public health; addressing the health impacts of climate change; improving women’s health; and advancing the biomedical research enterprise. As leaders inside and outside government navigate complex challenges, the Vital Directions series provides nonpartisan, evidence-based guidance.

Read the series >>
Virtual Briefing
On February 27 from 12:00 to 1:00 pm ET the NAM will host a virtual briefing on key policy actions recommended by authors of the Vital Directions series.

Speakers include:
Michael McGinnis (Moderator), National Academy of Medicine
Victor J. Dzau, National Academy of Medicine
Don Metz, Interim Editor-in-Chief, Health Affairs
Don Berwick, Institute for Healthcare Improvement
Senator Bill Frist
Paula Johnson, Wellesley University
Michael Matheny, Vanderbilt University Medical Center
Mark McClellan, Duke Margolis Institute for Health Policy
E. Albert Reece, University of Maryland School of Medicine
Register Now
Join the conversation!

Share this! The top 6 priorities for health policy in 2025, according to experts from @theNAMedicine: AI in health care, payment and delivery reform, biomedical research, women’s health, climate and health, and modernizing public health. Read the new #NAMVitalDx series in @Health_Affairs: NAM.edu/VitalDirections

OPTIMIZING PATIENT OUTCOMES - BEYOND THE PACKAGE INSERT: APPROPRIATE INTERPRETATION OF TESTING RESULTS FOR TARGETED THERAPY SELECTION
February 28, 2025

https://education.nccn.org/node/96352

OVERVIEW
The armamentarium of targeted therapies for use in oncology is ever-growing. It is imperative that clinicians understand how to appropriately select therapies based on test results when considering factors such as the cutoff for “positivity”, or which genetic variant is actionable. But interpreting these results can be time consuming for the busy clinician, especially if they are unsure of where to turn for information. Education on this topic can provide useful information on how to find the necessary information required to accurately recommend the best therapy option.
TARGET AUDIENCE
This program is designed to meet the educational needs of physicians, nurses, nurse practitioners, pharmacists, physician associates/assistants and other health care professionals who treat patients with cancer.
LEARNING OBJECTIVES
Following this activity, participants should be able to:

Describe how to select appropriate testing methods to optimize biomarker detection and target therapy selection.
Recognize when it is necessary to look for information beyond the prescribing information to determine clinical actionability.
Demonstrate how to find information on the actionability of genetic variants by using a precision oncology database.
ADDITIONAL INFORMATION
SUPPORTERS:
Supported by educational grants from:

AstraZeneca
Genentech, a member of the Roche Group
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

COURSE SUMMARY
Available credit:
1.00 AAPA Category 1 CME credit
1.00 ACPE contact hours
1.00 AMA PRA Category 1 Credit™
1.00 ANCC contact hours
1.00 ANCC Pharmacology Contact Hours
1.00 Participation
Course opens:
01

https://education.nccn.org/node/96352

 Beyond the Package Insert: Appropriate Interpretation of Testing Results for Targeted Therapy Selection